The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Mead Johnson Nutrition Co

NYSE: MJN
Last

(U.S.) $100.58

Today's change+2.00 +2.03%
Updated December 18 4:04 PM EST. Delayed by at least 15 minutes.
 

Mead Johnson Nutrition Co

NYSE: MJN
Last

(U.S.) $100.58

Today's change+2.00 +2.03%
Updated December 18 4:04 PM EST. Delayed by at least 15 minutes.

Mead Johnson Nutrition Co crosses above 50-day moving average

Mead Johnson Nutrition Co closed up sharply Thursday, rallying (U.S.)$2.00 or 2.03% to (U.S.)$100.58 and crossing above its 50-day moving average. Shares have lost 1.38% over the last five days, but sit 4.11% below their 52-week high. This security has outperformed the S&P 500 by 6.01% during the last year.

Key company metrics

  • Open(U.S.) $100.45
  • Previous close(U.S.) $98.58
  • High(U.S.) $100.61
  • Low(U.S.) $99.43
  • Bid / Ask(U.S.) $94.85 / (U.S.) $103.50
  • YTD % change+20.08%
  • Volume1,851,487
  • Average volume (10-day)1,320,460
  • Average volume (1-month)1,122,619
  • Average volume (3-month)1,374,507
  • 52-week range(U.S.) $73.23 to (U.S.) $104.89
  • Beta0.70
  • Trailing P/E28.59×
  • P/E 1 year forward26.53×
  • Forward PEG2.65×
  • Indicated annual dividend(U.S.) $1.50
  • Dividend yield1.49%
  • Trailing EPS(U.S.) $3.52
Updated December 18 4:04 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+16.66%

Based on its net profit margin of 16.66%, Mead Johnson Nutrition Co is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.93%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Food Processing
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue1,0911,1111,1131,061
Total other revenue--------
Total revenue1,0911,1111,1131,061
Gross profit653684708669
Total cost of revenue438427406392
Total operating expense848866822856
Selling / general / administrative399417389420
Research & development29272728
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)0----21
Other operating expenses, total-90-2-8
Operating income243245291205
Interest income (expense), net non-operating-21-18-15-14
Gain (loss) on sale of assets--------
Other--------
Income before tax224230279194
Income after tax188176208157
Income tax, total36547137
Net income188171202153
Total adjustments to net income0000
Net income before extra. items188171202153
Minority interest-1-5-5-4
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items187171202153
Inc. avail. to common incl. extra. items187171202153
Diluted net income187171202153
Dilution adjustment------0
Diluted weighted average shares203203203203
Diluted EPS excluding extraordinary itemsvalue per share0.920.841.000.75
Dividends per sharevalue per share0.380.380.340.34
Diluted normalized EPSvalue per share0.910.851.020.70